サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1742551

医療用ラジオアイソトープ市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測

Medical Radioisotopes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 215 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
医療用ラジオアイソトープ市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測
出版日: 2025年04月03日
発行: Transparency Market Research
ページ情報: 英文 215 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用ラジオアイソトープ市場- 調査範囲

TMRの調査レポート「医療用ラジオアイソトープの世界市場」は、2025～2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019～2035年までの世界の医療用ラジオアイソトープ市場の収益と予測を提供します。また、2025～2035年までの世界の医療用ラジオアイソトープ市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、医療用ラジオアイソトープ市場を推察しました。

市場スナップショット
2024年の市場規模 59億米ドル
2035年の市場規模 141億米ドル
CAGR 8.1%

当レポートでは、世界の医療用ラジオアイソトープ市場の競合情勢について調査しています。世界の医療用ラジオアイソトープ市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の医療用ラジオアイソトープ市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の医療用ラジオアイソトープ市場分析と予測、2020～2035年

第5章 主要洞察

  • 最近の進歩
  • ポーターのファイブフォース分析
  • PESTEL分析
  • バリューチェーン分析
  • 主要な業界イベント（合併、買収、提携、コラボレーションなど）
  • 価格分析（ブランド価格、地域/国別の平均販売価格）
  • 主要国別の規制シナリオ
  • 研究開発動向
  • 新規市場参入者のための市場開拓戦略

第6章 世界の市場分析および予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：タイプ別、2020～2035年
    • テクネチウム99m
    • ガリウム67
    • ヨウ素131
    • 銅-67
    • コバルト60
    • ストロンチウム82
    • ゲルマニウム68
    • ルビジウム82
    • タリウム201
    • その他
  • 市場の魅力分析：タイプ別

第7章 世界の市場分析および予測：用途別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：用途別、2020～2035年
    • 心臓病学
    • 腫瘍学
    • 神経学
    • 腎臓学
    • 甲状腺
    • その他
  • 市場の魅力分析：用途別

第8章 世界の市場分析および予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：エンドユーザー別、2020～2035年
    • 病院
    • 診断センター
    • その他
  • 市場の魅力分析：エンドユーザー別

第9章 世界の市場分析および予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020～2035年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋地域の市場分析と予測

第13章 ラテンアメリカ地域の市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • Siemens Healthineers
    • Lantheus Holdings
    • Abbott Laboratories
    • Eli Lilly
    • Sanofi
    • Orano
    • Rosatom
    • Cardinal Health
    • Curium
    • IBA Radiopharma Solutions
    • NorthStar Medical Radioisotopes
    • BWX Technologies
    • Shine Medical Technologies
    • NECSA Ltd
図表

List of Tables

  • Table 01: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 03: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 04: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 07: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 08: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 09: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 10: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 11: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 12: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 13: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 15: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 16: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 17: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 19: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 20: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 21: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 23: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 24: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 03: Global Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 04: Global Medical Radioisotopes Market Revenue (US$ Bn), by Technetium-99m, 2020-2035
  • Figure 05: Global Medical Radioisotopes Market Revenue (US$ Bn), by Gallium-67, 2020-2035
  • Figure 06: Global Medical Radioisotopes Market Revenue (US$ Bn), by Iodine-131, 2020-2035
  • Figure 07: Global Medical Radioisotopes Market Revenue (US$ Bn), by Copper-67, 2020-2035
  • Figure 08: Global Medical Radioisotopes Market Revenue (US$ Bn), by Cobalt-60, 2020-2035
  • Figure 09: Global Medical Radioisotopes Market Revenue (US$ Bn), by Strontium-82, 2020-2035
  • Figure 10: Global Medical Radioisotopes Market Revenue (US$ Bn), by Germanium-68, 2020-2035
  • Figure 11: Global Medical Radioisotopes Market Revenue (US$ Bn), by Rubidium-82, 2020-2035
  • Figure 12: Global Medical Radioisotopes Market Revenue (US$ Bn), by Thallium-201, 2020-2035
  • Figure 13: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 14: Global Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 15: Global Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 16: Global Medical Radioisotopes Market Revenue (US$ Bn), by Cardiology, 2020-2035
  • Figure 17: Global Medical Radioisotopes Market Revenue (US$ Bn), by Oncology, 2020-2035
  • Figure 18: Global Medical Radioisotopes Market Revenue (US$ Bn), by Neurology, 2020-2035
  • Figure 19: Global Medical Radioisotopes Market Revenue (US$ Bn), by Nephrology, 2020-2035
  • Figure 20: Global Medical Radioisotopes Market Revenue (US$ Bn), by Thyroid, 2020-2035
  • Figure 21: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 22: Global Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 23: Global Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 24: Global Medical Radioisotopes Market Revenue (US$ Bn), by Hospitals, 2020-2035
  • Figure 25: Global Medical Radioisotopes Market Revenue (US$ Bn), by Diagnostic Centers, 2020-2035
  • Figure 26: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 27: Global Medical Radioisotopes Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 28: Global Medical Radioisotopes Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 29: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 30: North America - Medical Radioisotopes Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 31: North America - Medical Radioisotopes Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 32: North America - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 33: North America - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 34: North America - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 35: North America - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 36: North America - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 37: North America - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 38: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 39: Europe - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 40: Europe - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 41: Europe - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 42: Europe - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 43: Europe - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 44: Europe - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 45: Europe - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 46: Europe - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 47: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 50: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 51: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 52: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 53: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 54: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 55: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 56: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 57: Latin America - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 58: Latin America - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 59: Latin America - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 60: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 61: Latin America - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 62: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 63: Latin America - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 64: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 65: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 66: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 67: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 68: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 69: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 70: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 71: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 72: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 73: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
目次
Product Code: TMRGL86586

Medical Radioisotopes Market - Scope of Report

TMR's report on the global medical radioisotopes market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global medical radioisotopes market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical radioisotopes market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical radioisotopes market.

Market Snapshot
Market Value in 2024US$ 5.9 Bn
Market Value in 2035US$ 14.1 Bn
CAGR8.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical radioisotopes market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical radioisotopes market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical radioisotopes market.

The report delves into the competitive landscape of the global medical radioisotopes market. Key players operating in the global medical radioisotopes market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical radioisotopes market profiled in this report.

Key Questions Answered in global medical radioisotopes Market Report:

  • What is the sales/revenue generated by medical radioisotopes across all regions during the forecast period?
  • What are the opportunities in the global medical radioisotopes market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Medical Radioisotopes Market - Research Objectives and Research Approach

The comprehensive report on the global medical radioisotopes market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global medical radioisotopes market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical radioisotopes market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Radioisotopes Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Medical Radioisotopes Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Recent Advancements
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Value Chain Analysis
  • 5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
  • 5.7. Regulatory Scenario by Key Country
  • 5.8. Research and Development Trends
  • 5.9. Go-to-Market Strategy for New Market Entrants

6. Global Medical Radioisotopes Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020-2035
    • 6.3.1. Technetium-99m
    • 6.3.2. Gallium-67
    • 6.3.3. Iodine-131
    • 6.3.4. Copper-67
    • 6.3.5. Cobalt-60
    • 6.3.6. Strontium-82
    • 6.3.7. Germanium-68
    • 6.3.8. Rubidium-82
    • 6.3.9. Thallium-201
    • 6.3.10. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Medical Radioisotopes Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2035
    • 7.3.1. Cardiology
    • 7.3.2. Oncology
    • 7.3.3. Neurology
    • 7.3.4. Nephrology
    • 7.3.5. Thyroid
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Medical Radioisotopes Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2035
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Medical Radioisotopes Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Medical Radioisotopes Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2020-2035
    • 10.2.1. Technetium-99m
    • 10.2.2. Gallium-67
    • 10.2.3. Iodine-131
    • 10.2.4. Copper-67
    • 10.2.5. Cobalt-60
    • 10.2.6. Strontium-82
    • 10.2.7. Germanium-68
    • 10.2.8. Rubidium-82
    • 10.2.9. Thallium-201
    • 10.2.10. Others
  • 10.3. Market Value Forecast, by Application, 2020-2035
    • 10.3.1. Cardiology
    • 10.3.2. Oncology
    • 10.3.3. Neurology
    • 10.3.4. Nephrology
    • 10.3.5. Thyroid
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2020-2035
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostics Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Medical Radioisotopes Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2020-2035
    • 11.2.1. Technetium-99m
    • 11.2.2. Gallium-67
    • 11.2.3. Iodine-131
    • 11.2.4. Copper-67
    • 11.2.5. Cobalt-60
    • 11.2.6. Strontium-82
    • 11.2.7. Germanium-68
    • 11.2.8. Rubidium-82
    • 11.2.9. Thallium-201
    • 11.2.10. Others
  • 11.3. Market Value Forecast, by Application, 2020-2035
    • 11.3.1. Cardiology
    • 11.3.2. Oncology
    • 11.3.3. Neurology
    • 11.3.4. Nephrology
    • 11.3.5. Thyroid
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2020-2035
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostics Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Medical Radioisotopes Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020-2035
    • 12.2.1. Technetium-99m
    • 12.2.2. Gallium-67
    • 12.2.3. Iodine-131
    • 12.2.4. Copper-67
    • 12.2.5. Cobalt-60
    • 12.2.6. Strontium-82
    • 12.2.7. Germanium-68
    • 12.2.8. Rubidium-82
    • 12.2.9. Thallium-201
    • 12.2.10. Others
  • 12.3. Market Value Forecast, by Application, 2020-2035
    • 12.3.1. Cardiology
    • 12.3.2. Oncology
    • 12.3.3. Neurology
    • 12.3.4. Nephrology
    • 12.3.5. Thyroid
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2020-2035
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostics Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Medical Radioisotopes Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020-2035
    • 13.2.1. Technetium-99m
    • 13.2.2. Gallium-67
    • 13.2.3. Iodine-131
    • 13.2.4. Copper-67
    • 13.2.5. Cobalt-60
    • 13.2.6. Strontium-82
    • 13.2.7. Germanium-68
    • 13.2.8. Rubidium-82
    • 13.2.9. Thallium-201
    • 13.2.10. Others
  • 13.3. Market Value Forecast, by Application, 2020-2035
    • 13.3.1. Cardiology
    • 13.3.2. Oncology
    • 13.3.3. Neurology
    • 13.3.4. Nephrology
    • 13.3.5. Thyroid
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2020-2035
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostics Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Medical Radioisotopes Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020-2035
    • 14.2.1. Technetium-99m
    • 14.2.2. Gallium-67
    • 14.2.3. Iodine-131
    • 14.2.4. Copper-67
    • 14.2.5. Cobalt-60
    • 14.2.6. Strontium-82
    • 14.2.7. Germanium-68
    • 14.2.8. Rubidium-82
    • 14.2.9. Thallium-201
    • 14.2.10. Others
  • 14.3. Market Value Forecast, by Application, 2020-2035
    • 14.3.1. Cardiology
    • 14.3.2. Oncology
    • 14.3.3. Neurology
    • 14.3.4. Nephrology
    • 14.3.5. Thyroid
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by End-user, 2020-2035
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostics Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Siemens Healthineers
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Lantheus Holdings
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Abbott Laboratories
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Eli Lilly
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Sanofi
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Orano
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Rosatom
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Cardinal Health
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Curium
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. IBA Radiopharma Solutions
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. NorthStar Medical Radioisotopes
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. BWX Technologies
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Shine Medical Technologies
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. NECSA Ltd
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments